NCT00783640

CompletedPhase 3

Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACAC_L_04371

Study Type

interventional

Actual enrollment (reported)

27

Locations

1 country

Sites

1

Timeline

Study Start

October 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

November 2008

Actual (reported)

Study Completion

Not reported

Date not reported

Brief Summary

To demonstrate the absence of photoirritation and photosensitization potential of the product Dermacyd Femina (Lactic Acid) Pocket BR.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 27 participants
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
October 31, 2008
Actual (reported)
Primary Completion
November 2008
Actual (reported)
First Posted
November 3, 2008
Actual (reported)

Last Updated: December 19, 2008
Status Verified: December 2008
Last Update Submitted: December 18, 2008

Conditions

Hygiene

Outcome Measures

Primary Outcomes (2)

The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale.
Throughout the study
The sensibility will be evaluated according to the skin type.
Throughout the study

Study Arms (1)

1

EXPERIMENTAL

Lactic Acid

Drug: Lactic Acid

Interventions

Lactic AcidDrug

Drug: Lactic Acid (Dermacyd Femina)

1

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Age between 18 and 60 years old;
Phototype Skin I,II, III e IV

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-Aventis Administrative Office

São Paulo, Brazil

MeSH Terms

Interventions

Lactic Acid

Intervention Hierarchy (Ancestors)

LactatesHydroxy AcidsCarboxylic AcidsOrganic Chemicals

Study Officials

Jaderson Lima
Sanofi
STUDY DIRECTOR

Enrollment

27 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 3
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

October 31, 2008

First Posted

November 3, 2008

Study Start

October 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT00761800

Dermacyd Teen Care Tangerina Mix - Compatibility

Phase 3Completed

NCT00794612

Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.

Phase 3Completed

NCT00712868

Acceptability of Lactacyd Femina

Phase 4Completed

NCT00705744

Dermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.

Phase 3Completed

NCT00705276

Dermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity Potential

Phase 3Completed

NCT00793026

Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability

Phase 3Completed

Integral skin test in the region;

Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

You may not qualify if:

Lactation or gestation
Use of Antiinflammatory and/or immunosuppression drugs one month before the study;
Personnel history of atopy;
History of sensitivity or irritation for topic products;
Active cutaneous disease;
Use of new drugs or cosmetics during the study;
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Contact the study team to confirm eligibility.

Primary Completion

November 2008

Actual (reported)

Last Updated

December 19, 2008

Record last verified: 2008-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00783640
Data provider: ClinicalTrials.gov
Source updated: 2008-12-19
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:25:09 UTC

Locations

BR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

Primary Completion

First Posted

Conditions

Outcome Measures

Primary Outcomes (2)

Study Arms (1)

1

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations